Concepedia

Michael B. Fisher

MB

58

Publications

4K

Citations

30

H-Index

1914

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Pfizer (United States)

University of Washington

University of Leeds

Boehringer Ingelheim (United States)

Michael B. Fisher is an author at University of North Carolina at Chapel Hill specializing in medicine, biochemistry, and natural sciences.

ORCID

Top concepts

Publications per year

1914–2022

58

Publications

58

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

Paul S. Changelian, Mark E. Flanagan, Douglas J. Ball et al. · Science · 2003 · 667 citations · Full text

, , +21

In Vitro Glucuronidation Using Human Liver Microsomes and The Pore-Forming Peptide Alamethicin

Michael B. Fisher, Kristina Campanale, Bradley L. Ackermann et al. · Drug Metabolism and Disposition · 2000 · 339 citations

Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection

Mark E. Flanagan, Todd A. Blumenkopf, William H. Brissette et al. · Journal of Medicinal Chemistry · 2010 · 331 citations · Full text

, , +19

Amantadine Treatment of Fatigue Associated With Multiple Sclerosis

Ronald A. Cohen, Michael B. Fisher · Archives of Neurology · 1989 · 203 citations

Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid

Abu Jafar Md. Sadeque, Michael B. Fisher, Kenneth R. Korzekwa et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 157 citations

Rows per page

1–5 of 58